You are here:

ivabradine (Procoralan)

Advice

in the absence of a submission from the holder of the marketing authorisation:

ivabradine (Procoralan®)  is not recommended for use within NHS Scotland.

Indication under review: Symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm, in combination with beta-blockers, in patients inadequately controlled with an optimal beta-blocker dose and whose heart rate is > 60 bpm.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.
 

Drug Details

Drug Name: ivabradine (Procoralan)
SMC Drug ID: 689/11
Manufacturer: Servier Laboratories Ltd
Indication: Symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm, in combination with beta-blockers, in patients inadequately controlled with an optimal beta-blocker dose and whose heart rate is > 60 bpm.
BNF Category:
Sub Category: 2.6 Nitrates calcium-channel blockers and other antianginal drugs
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 7 February 2011

Back